ECM-derived scaffolds have previously been developed from devitalized native cartilage and successfully used in tissue engineering. Such ECM based biomaterials are commonly derived from animal tissue, which may not represent the ideal source for applications in human. Native human ECM can be used as an alternative to xenogeneic tissue; however its supply may be limited leading to the need for a more readily available source of such biomaterials. The objective of this study was to compare devitalized native and tissue engineered cartilaginous ECM as chondro-permissive scaffolds for tissue engineering. To this end, porous scaffolds were produced using ECM derived from porcine articular cartilage and cartilaginous sheets engineered using human bone marrow stem cells.
INTRODUCTION
Articular cartilage is a complex avascular tissue with limited capacity for self repair 1 .
Injuries to cartilage can be treated using different strategies, including cell-based therapies 1a .
Tissue engineering is a promising approach to regenerate tissues and organs through the use of cells, scaffolds, biochemical and biophysical cues 2 . Scaffolds can be engineered to facilitate cell adhesion, proliferation and consequent differentiation, often by mimicking aspects of the biochemical and biophysical characteristics of the native extracellular-matrix (ECM) 3 . In particular, decellularized or devitalized ECM-derived scaffolds have been developed from numerous different tissues and used in regenerative medicine 4 . The success of ECM-derived scaffolds is dependent on the host response following implantation 5 . The immune response to such scaffolds is dependent on several factors, including fabrication methods and the origin of the ECM 5 .
Cartilage ECM-derived scaffolds have been shown to be chondro-permissive and to facilitate articular cartilage repair 4a, 6 . In general, however, such approaches rely on the use of animal-derived tissues (xenogeneic), with the associated risk of an adverse immune response and disease transmission after implantation into human 7 . As an alternative to the use of xenogeneic tissues, native human cartilage ECM (either autogeneic or allogeneic) has also been used as a scaffold for joint regeneration 7a, 8 . However, the supply of such native human tissues is limited, and there are concerns related to disease transmission with allogeneic approaches, motivating the use of in vitro engineered cartilage ECM from human chondrocytes or mesenchymal stem cells (MSCs) 9 . In addition to lowering the risk of disease transmission and eliciting an adverse immune response, engineered ECM-derived scaffolds could be considered to be more developmentally immature and hence provide a milieu of features more conductive to chondrogenesis 9b . Engineered cartilage ECM is compositionally different to native articular cartilage, which impacts how cells and growth factors interact 4 with scaffolds generated using such biomaterials 3d . For example, chordin-cysteine binding sites, which are not available in mature cartilage ECM, can bind to transforming growth factor-beta (TGF-β) family growth factors in more immature tissue 3d . This interaction between collagen and TGF-β is expected to regulate chondrogenesis of stem cells 9b, 10 .
The goal of this set of experiments was to compare devitalized native and engineered cartilage ECM as chondro-permissive scaffolds for cartilage tissue engineering. Engineered tissues were produced from high density cultures of bone marrow MSCs that self-assembled to generate cartilaginous constructs 11 . To enhance chondrogenesis, TGF-β1 releasing gelatin microspheres were combined with these MSCs 9c . These microspheres, when included in high density sheets of MSCs, can uniformly deliver chondrogenic growth factor over a sustained period, enabling homogenous differentiation and robust cartilage tissue formation compared to supplementing the media with growth factor 9c . Therefore the goal for this study was to evaluate if scaffolds produced using ECM engineered in the presence of such TGF-β1 loaded microspheres would be more chondro-permissive. Hence, we sought to develop and assess the chondro-inductivity of ECM-derived scaffolds generated from three different types of ECM: (1) porcine ECM (Native), (2) in vitro engineered sheets of cartilage (Eng) and (3) in vitro engineered cartilage sheets generated in the presence of growth factor releasing microspheres (Eng-MS), see Figure 1 . To access the potential of these different scaffolds to support chondrogenesis, infrapatellar fat pad human stem cells (FPSCs) were incorporated onto the ECM matrices and chondrogenesis assessed over 28 days. An additional goal of the current set of experiments was to assess the potential of engineered ECM scaffolds to perform as growth factor delivery platform to enhance chondrogenesis of adult stem cells.
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MATERIAL AND METHODS
Harvest of Porcine Cartilage ECM
Native cartilage tissue was harvested in aseptic conditions as previously described 6b, 6c . Briefly, porcine articular cartilage was collected in femoral condyles, the patella groove and the tibial plateau of pigs (Female; 3 month) using a biopsy punch (diameter 8 mm). The pigs were not sacrificed specifically for this study; the cartilaginous tissue was harvested from the pigs after they were sacrificed for an unrelated study. Cartilage was washed and kept in phosphate buffered saline (PBS; Sigma-Aldrich) containing penicillin (100 U ml -1 )-streptomycin (100 µg ml -1 ; GIBCO, Biosciences).
Engineering of Human Cartilaginous ECM using Bone Marrow-derived
Mesenchymal Stem Cells
As previously described 12 human infrapatellar fat pad-derived stem cells.
Scanning Electron Microscopy, Mean Pore Size and Mechanical Testing
To analyze such porous scaffolds, scanning electron microscopy (SEM) was used.
Briefly, structures were fixed in 4% paraformaldehyde solution (PFA, Sigma-Aldrich)
overnight. Secondly, scaffolds were dehydrated (ethanol 10-100%), and examined under a scanning electron microscope (SEM; Tescan Mira FEG-SEM XMU, Libušina, Czech Republic). Pore size quantification was performed by calculating the diameter of numerous pores (40; in Image J) in SEM micrographs of the scaffolds (n=3) previous to cell seeding 6b, 9 14 . Scaffolds (dry and acellular; 5 mm diameter; 3 mm height) were assessed in terms of mechanical performance with a 5 N load cell (Zwick Z005, Roell, Germany) 15 . Specifically, assessment was preceded by a 0.03 N load to allow proper contact with the loading platens.
Additionally, samples were subjected to compressive strain (10%; 0.001 mm/s), and the Young's modulus was determined (slope of the stress-strain curve). After a four week culture period cartilaginous constructs were assessed mechanically (compressive strain, 10%; 0.001 mm/s) in a bath of PBS (RT) until equilibrium was reached, as previously described 15 .
Cell Isolation and Culture
The consent for the use of human infrapatellar fat pad ( LaganBach Services) and 1% penicillin (100 U ml -1 )-streptomycin (100 µg ml -1 ) for four hours. A ratio of 4 ml/g of tissue of collagenase was found to be optimal 16 . Cells were washed, passed through a cell strainer (40 µm) and centrifuged (650 g; 5 minutes). The remaining cells were plated (5000 cells cm -2 ). The cell population was cultured (to P2) in DMEM-HG with 10% FBS and 1% penicillin (100 U ml -1 )-streptomycin (100 mg ml -1 ) with FGF-2 (5 ng ml -1 ; ProSpec-Tany TechnoGene Ltd, Israel).
0.5x10 6 human FPSCs were seeded into scaffolds (d=5 mm; h= 3 mm). Constructs were in chondrogenic medium 6b, 6c, 16b , for four weeks (5% O 2 ; 37˚C), kept in 12-well plates, and each was placed within agarose moulds (3% w/v; Sigma-Aldrich, Ireland; d=5 mm) to stop cell movement to the wells and increase cell-seeding efficiency. Chondrogenic medium consisted of DMEM GlutaMAXTM with penicillin (100 U ml -1 )-streptomycin (100 µg ml -1 ), sodium pyruvate (100 µg ml -1 ), L-proline (40 µg ml -1 ), L-ascorbic acid-2-phosphate (50 µg ml -1 ), bovine serum albumin (1.5 mg ml -1 ), insulin-transferrin-selenium (1x), dexamethasone (100 nM) (all from Sigma-Aldrich, Ireland) and transforming growth factor-β3 (TGF-β3, 10 ng ml -1 ; ProSpec-Tany TechnoGene Ltd, Israel).
In addition to adding TGF-β3 into the media, we also examined if this growth factor could instead be soak loaded onto the scaffold. In this way, the ECM construct would deliver TGF-β3. For these groups (Eng+ and Eng-MS+) no TGF-β3 was additionally supplemented during culture. Instead, TGF-β3 (200 ng), in 40 µl of medium, was soak-loaded into the ECM-derived scaffold with cells for 15 minutes. After seeding the scaffold with cells were left in the incubator for 2 hours. Furthermore, 2.5 ml of chondrogenic media (without TGF-β3) was added, and repeated twice a week (2.5 ml per well).
Biochemical analysis
Biochemical analyses were performed for day 0 and 28 constructs, for glycosaminoglycan (sGAG), collagen, and DNA content, as presented elsewhere 6c, 14 .
Constructs were digested by incubation in papain (125 μg ml -1 ) in sodium acetate (0.1 M), cysteine-HCl (5 mM), Ethylenediaminetetraacetic acid (EDTA) (0.05 M), pH 6.0 (all from Sigma-Aldrich, Ireland) at 60˚C (10 rpm; 18 hours). DNA content of each sample was determined with Hoechst Bisbenzimide 33258, with a calf thymus DNA standard 14 .
Proteoglycan content was determined by sGAG quantification in constructs with dimethylmethylene blue dye-binding assay (Blyscan, Biocolor Ltd.). Collagen was quantified by hydroxyproline content, following hydrolysis (110°C; 18 hours) in HCL (38%), and assayed using chloramine-T assay with a hydroxyproline/collagen ratio of 1:7.69 16a . All 11 experimental data presented corresponds to a minimum of four analyzed constructs per group, and all the experiments were repeated twice.
Histology and Immunohistochemistry
As previously described 6b, 6c , constructs were fixed (4˚C) in paraformaldehyde (4%) (Sigma-Aldrich), followed by washing steps and paraffin embedded. Samples were sectioned and dyed with picro-sirius red for collagen, 1% alcian blue 8GX (Sigma-Aldrich) in HCl (0.1 M) for sGAG , and with 0.1% nuclear fast red solution (Sigma-Aldrich) for cell nuclei. To image the orientation/organization of the collagen fibril, picro-sirius red dyed samples were analyzed with in polarized light (Nikon Eclipse E400 POL), as previously described 17 .
Alizarin calcium staining was performed to assess calcium accumulation 18 . As previously 
Measurement of TGF-β3 present in ECM scaffolds
The TGF-β3 present in the ECM-derived scaffolds before seeding with FPSC was measured using a previously reported protocol 19 . Briefly, the scaffolds were treated with a added and the optical density was determined (450 nm).
Statistical Analysis
Statistical results were obtained with MINITAB 15.1 software package (Minitab Ltd., Coventry, UK), and presented as mean±SD. Groups were analyzed for significant differences using a general linear model for analysis of variance (ANOVA) with factors including ECM and growth factor delivery. Tukey's test for multiple comparisons was used, with significance accepted for p<0.05.
RESULTS
Engineered and native cartilage ECM are compositionally distinct
Porous scaffolds were fabricated using three different cartilage ECM derived materials: (1) native porcine articular cartilage (Native); (2) engineered cartilage (Eng); and (3) cartilage engineered with TGF-β1 loaded microspheres (Eng-MS). Prior to forming scaffolds using these materials, their ECM composition was compared (Figure 2 ). Both the 13 Eng and Eng-MS tissues stained strongly for glycosaminoglycans ( Figure 2G and L), comparable to native articular cartilage ( Figure 2B ). Native tissue stained more intensely for collagen compared to engineered tissues ( Figure 2C , H, and M). Polarized light microscopy (PLM) revealed that engineered tissues did not possess the same degree of cartilage fibril organization as native articular cartilage ( Figure 2D ). All tissues stained negatively for calcium accumulation ( Figure 2E , J and O). Immunohistochemistry was used to determine the specific types of collagen within the different ECMs. The native, Eng and Eng-MS tissues all stained weakly for type I collagen deposition ( Figure 3A , D, and G). As expected, native cartilage stained strongly for type II collagen ( Figure 3B ), but engineered ECM stained less intensely. Eng-MS constructs stained slightly more intensely for type II collagen than the Eng group ( Figure 3H ). Weak staining for type X collagen was present in native and Eng ( Figure 3C and F) tissues. Type X collagen staining was slightly more intense in the Eng-MS group ( Figure 3I ). 
Native and engineered (Eng and Eng-MS) ECM-derived scaffolds support chondrogenesis of stem cells
Porous scaffolds were firstly produced by a previously described freeze drying protocol 6b using devitalized native (Native) and engineered ECM (Eng and Eng-MS). There were no significant differences in collagen and GAG levels and morphology between Eng and Eng-MS scaffolds (data not shown), so only data for Native and Eng scaffolds are presented here. SEM was used to characterize the porosity of both native and Eng scaffolds ( Figure 4A-D) . The architecture ( Figure 4A-D) , porosity, Young's modulus (Native: 34±8 kPa; Eng: 30± 4 kPa; Figure 4E ) and mean pore size (~70 μm) was comparable for all scaffold types ( Figure 4F ). Both native and Eng scaffolds stained positive for GAG ( Figure   4G and I), collagen ( Figure 4H and J), with the native scaffolds staining more intensely for type II collagen than Eng group ( Figure 4K and L). The GAG content was slightly higher for the Eng scaffolds (Native: 46±11 µg and Eng: 66±17 µg), while the collagen content of the 15 native ECM-derived scaffolds was higher than the Eng group (Native: 335±69 µg and Eng:
104±80 µg). TGF-β3 quantification was performed using ELISA to quantify the amount of growth factor present in each of the scaffold groups. Higher levels of TGF-β3 were present in 16 scaffolds engineered using Eng-MS ECM compared with the other groups, suggesting that incorporation of TGF-β1 releasing microspheres enhanced TGF-β3 production and accumulation within the engineered tissue and/or retention of the growth factor within the matrix throughout scaffold fabrication ( Figure 5M ).
To assess the capacity of the scaffolds to support chondrogenesis, they were seeded with FPSCs and maintained in culture for 4 weeks in media continuously supplemented with TGF-β3. In such conditions, both native and engineered (Eng and Eng-MS) scaffolds supported the development of engineered tissues that resembled cartilage macroscopically ( Figure 5A , E and I). Histological analysis suggested that GAG and collagen deposition was higher within native ECM scaffolds compared to the engineered ECM scaffolds ( Figure 5B and C). In addition, type II collagen deposition was more intense in native cartilage ECM scaffolds ( Figure 5D ). When comparing the engineered ECM scaffold groups, type II collagen immuno-staining appeared slightly more intense in tissues engineered within the Eng-MS ECM-derived scaffolds ( Figure 5L ). Quantitative biochemical assays revealed that the DNA, GAG and collagen content was higher in the native scaffolds when compared to the Eng group (***p<0.001; Figure 5N -P), although no differences in GAG accumulation was observed between the native and Eng-MS scaffolds (***p<0.001; Figure 5N -P). In addition, the Eng-MS ECM-derived constructs accumulated higher levels of GAG and collagen compared to the Eng scaffolds ( Figure 5O ). The equilibrium moduli of the three different constructs were not statistically different ( Figure 5Q ). Finally, alizarin red staining revealed no calcification in any of the engineered groups (data not shown). were subtracted from the total DNA content: Native-1.9±0.6 µg, Eng-2.9±0.4 µg and Eng-MS 2.5±0.2 µg), GAG (O), Collagen (P) and Equilibrium Modulus (Q) for native, Eng and Eng-MS groups for 28 days culture period (n=5; *p<0.05; ***p<0.001). Scale bar: 50 µm.
Engineered ECM derived scaffolds can be used as TGF-β3 releasing systems to promote chondrogenesis of adult stem cells
It was shown that native cartilage ECM scaffolds can act as reservoirs of TGF-β3, inducing robust chondrogenesis of FPSCs 6b, 6c . To assess if engineered cartilage ECM scaffolds could perform in a similar manner, these were laden with growth factor (TGF-β3), seeded with FPSCs and maintained in culture for 28 days. No other exogenous growth factor 18 was added to the medium for the rest of the culture period. At the end of this 28 day culture period, the Eng+ and Eng-MS+ constructs resembled cartilage macroscopically ( Figure 6A and E). GAG and collagen histological staining was similar for the Eng+ and Eng-MS+ groups ( Figure 6B , C, F, and G). Immunohistochemistry results for type II collagen was similar for constructs fabricated using Eng+ and Eng-MS+ engineered cartilage ( Figure 6D and H). Biochemical sGAG quantification was comparable for Eng+ and Eng-MS+ constructs ( Figure 6I) , and of a similar order of magnitude to that observed when growth factor was continuously supplemented into the medium ( Figure 5O ). 
DISCUSSION
The purpose of the aforementioned work was to evaluate the potential of devitalized Scaffolds derived from devitalized cartilaginous ECM that was engineered with TGF-β1 loaded microspheres contained higher levels of remnant TGF-β3 than all other scaffolds.
This demonstrates that the strategy used to engineer the cartilaginous ECM determines the synthesis of growth factors by MSCs during this period. These higher levels of remnant growth factors could clarify the greater chondrogenesis in Eng-MS scaffolds when compared with Eng groups. Further support for the aforementioned hypothesis is given by the finding that when TGF-β3 was directly incorporated in the scaffold prior to cell seeding, the Eng+ and Eng-MS+ ECM-derived scaffolds supported similar levels of cartilage specific matrix deposition, strongly suggesting that local growth factor availability within these scaffolds is critical to ensuring robust chondrogenesis of adult stem cells. When TGF-β3 is media supplemented, growth factor transport limitations may occur due to slow diffusion through the construct, as well as preferential TGF-β3 uptake by cells in the scaffold periphery 9c, 22 .
Together these results suggest that the specific mode of growth factor presentation will influence the development of cartilaginous constructs within these porous ECM-derived scaffolds.
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Further studies need to be performed with the aim of understanding the role of devitalization/decellularization on the potential of such ECM-derived structures to enhance chondrogenic differentiation and cartilage regeneration, while keeping in mind the immune/inflammatory response. The engineered human ECM-derived scaffolds developed in this study were able to support robust chondrogenesis of FPSCs, especially when loaded with growth factor (TGF-β3). Engineered tissue maturity also needs to be taken into account, because, for example, the degree of development and composition of the ECM used for scaffold fabrication can dictate chondrogenic growth factor sequestration and availability to the cells 3d, 9b . It is relevant to plan future studies where scaffold composition is assessed, as the ratio of collagen to GAG will directly influence chondrogenesis of mesenchymal stem cells within such ECM derived biomaterials 9b, 23 .
CONCLUSION
This study describes a viable method to use ECM extracted from engineered human cartilage as a material to fabricate chondro-permissive scaffolds for cartilage regeneration. By seeding these scaffolds with infrapatellar fat pad stem cells, it was possible to engineer robust cartilage-like tissues in vitro. The use of such engineered ECM-derived scaffolds could overcome the limitations associated with autogeneic, allogeneic and xenogeneic decellularized tissue grafts. These engineered ECM-derived scaffolds could potentially be used as "off-the-shelf" chondro-permissive scaffolds to support cartilage regeneration. 
